Carfilzomib Combined with Thalidomide and Dexamethasone (CTD) Is an Highly Effective Induction and Consolidation Treatment in Newly Diagnosed Patients with Multiple Myeloma (MM) Who Are Transplant Candidate

被引：0
|
作者：
Sonneveld, Pieter [1 ]
Asselbergs, Emilie [1 ]
Zweegman, Sonja [2 ]
Van der Holt, Bronno [3 ]
Kersten, Marie Jose [4 ]
Vellenga, Edo [5 ]
van Marwijk-Kooy, Marinus [6 ]
de Weerdt, Okke [7 ]
Lonergan, Sarah
Lokhorst, Henk [8 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands
[3] Erasmus MC, HOVON Data Ctr, Rotterdam, Netherlands
[4] AMC, Amsterdam, Netherlands
[5] Univ Med Ctr Groningen UMCG, Groningen, Netherlands
[6] Isala Clin, Zwolle, Netherlands
[7] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands
[8] Univ Med Ctr Utrecht, Dept Hematol, Utrecht, Netherlands
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.333.333
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
333
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase II Clinical and Correlative Study of Carfilzomib, Lenalidomide, and Dexamethasone (CRd) in Newly Diagnosed Multiple Myeloma (MM) Patients
    Korde, Neha
    Zingone, Adriana
    Kwok, Mary
    Manasanch, Elisabet E.
    Costello, Rene
    Zuchlinski, Diamond
    Mulquin, Marcia
    Maric, Irina
    Calvo, Katherine R.
    Braylan, Raul C.
    Yuan, Constance
    Tembhare, Prashant Ramesh
    Stetler-Stevenson, Maryalice
    Arthur, Diane C.
    Raffeld, Mark
    Xi, Liqiang
    Choyke, Peter
    Kurdziel, Karen
    Lindenberg, Liza
    Steinberg, Seth M.
    Roschewski, Mark
    Landgren, Ola
    BLOOD, 2012, 120 (21)
  • [32] Superiority of Triple Combination Bortezomib plus Cyclophosphamide and Dexamethasone (VCD) Versus Thalidomide plus Cyclophosphamide and Dexamethasone (CTD) in Newly Diagnosed Multiple Myeloma Transplant-Eligible Patients
    Crusoe, Edvan De Queiroz
    Higashi, Fabiana
    Martinez, Gracia
    Bittencourt, Rosane
    Maiolino, Angelo
    Sousa, Lais
    Nunes, Renata Ferreira Marques
    Ribeiro, Glaciano
    Nicacio, Jandir
    Zanella, Karla Richter
    Magalhaes, Andre
    Leao, Danielle
    Pinto Neto, Jorge Vaz
    Hallack Neto, Abrahao Elias
    Braga, Walter
    Souza, Emmanuella G.
    Guimaraes, Antonio Julio A. M.
    Durigon, Giovanna Steffenello
    Laks, Dani
    Kutner, Jose Mauro
    Colli, Gilberto
    Santucci, Rodrigo
    Magalhaes, Roberto Jose Pessoa
    Hungria, Vania T. M.
    BLOOD, 2017, 130
  • [33] Carfilzomib Is Safe and Effective in Newly Diagnosed Patients with Multiple Myeloma with Renal Involvement
    Diamond, Benjamin
    Jayabalan, David S.
    Pearse, Roger
    Perry, Art
    Pekle, Karen
    Niesvizky, Ruben
    Rossi, Adriana C.
    BLOOD, 2017, 130
  • [34] CCNU, Idarubicin & Dexamethasone (CIDEX) - An effective oral treatment in newly diagnosed and relapsed patients with multiple myeloma (MM.)
    Brito-Babapulle, F
    Giannoutsos, L
    Maboreke, T
    BLOOD, 2001, 98 (11) : 308B - 308B
  • [35] Bortezomib, dexamethasone plus thalidomide for treatment of newly diagnosed multiple myeloma patients with or without renal impairment
    Guangzhong Yang
    Wenming Chen
    Yin Wu
    Chinese Journal of Cancer Research, 2013, 25 (02) : 155 - 160
  • [36] Bortezomib, dexamethasone plus thalidomide for treatment of newly diagnosed multiple myeloma patients with or without renal impairment
    Yang, Guangzhong
    Chen, Wenming
    Wu, Yin
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (02) : 155 - 160
  • [37] Lenalidomide, Bortezomib, and Dexamethasone (RVD) As Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)
    Joseph, Nisha
    Almaula, Dhwani
    Gleason, Charise
    Heffner, Leonard
    Boise, Lawrence H.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Nooka, Ajay
    BLOOD, 2017, 130
  • [38] Lenalidomide Combined With Cyclophosphamide and Dexamethasone Is Effective and Well Tolerated Induction Treatment For Newly Diagnosed Myeloma Patients Of All Ages
    Pawlyn, Charlotte
    Brioli, Annamaria
    Gregory, Walter
    Hinsley, Samantha
    Lindsay, Jindriska
    Cook, Gordon
    Milligan, Donald
    Chapman, Claire
    Owen, Roger G.
    Drayson, Mark T.
    Russell, Nigel
    Jackson, Graham H.
    Davies, Faith E.
    Morgan, Gareth J.
    BLOOD, 2013, 122 (21)
  • [39] Dexamethasone plus Thalidomide (Dex/Thal) compared to VAD as a pre-transplant treatment in newly diagnosed multiple myeloma (MM): A randomized trial.
    Macro, Margaret
    Divine, Marine
    Uzunhan, Yurdagul
    Jaccard, Arnaud
    Bouscary, Didier
    Leblond, Veronique
    Janvier, Maud
    Genet, Philippe
    Castaigne, Sylvie
    Royer, Bruno
    Allard, Christian
    Chevret, Sylvie
    Fermand, Jean-Paul
    BLOOD, 2006, 108 (11) : 22A - 22A
  • [40] Addition of bortezomib improves efficacy of thalidomide/dexamethasone in newly diagnosed patients with multiple myeloma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (02): : 78 - 79
12345